全文获取类型
收费全文 | 61149篇 |
免费 | 3917篇 |
国内免费 | 1742篇 |
专业分类
耳鼻咽喉 | 4136篇 |
儿科学 | 3167篇 |
妇产科学 | 1306篇 |
基础医学 | 5371篇 |
口腔科学 | 867篇 |
临床医学 | 5717篇 |
内科学 | 8184篇 |
皮肤病学 | 1945篇 |
神经病学 | 4711篇 |
特种医学 | 3165篇 |
外国民族医学 | 4篇 |
外科学 | 2597篇 |
综合类 | 7752篇 |
现状与发展 | 8篇 |
预防医学 | 5782篇 |
眼科学 | 617篇 |
药学 | 7194篇 |
44篇 | |
中国医学 | 2305篇 |
肿瘤学 | 1936篇 |
出版年
2024年 | 90篇 |
2023年 | 756篇 |
2022年 | 1547篇 |
2021年 | 2232篇 |
2020年 | 1895篇 |
2019年 | 1786篇 |
2018年 | 1812篇 |
2017年 | 1826篇 |
2016年 | 1905篇 |
2015年 | 2012篇 |
2014年 | 3583篇 |
2013年 | 4323篇 |
2012年 | 3605篇 |
2011年 | 3772篇 |
2010年 | 3012篇 |
2009年 | 2960篇 |
2008年 | 2977篇 |
2007年 | 3047篇 |
2006年 | 2633篇 |
2005年 | 2491篇 |
2004年 | 2038篇 |
2003年 | 1747篇 |
2002年 | 1458篇 |
2001年 | 1359篇 |
2000年 | 1203篇 |
1999年 | 1126篇 |
1998年 | 944篇 |
1997年 | 960篇 |
1996年 | 813篇 |
1995年 | 773篇 |
1994年 | 677篇 |
1993年 | 536篇 |
1992年 | 550篇 |
1991年 | 486篇 |
1990年 | 407篇 |
1989年 | 424篇 |
1988年 | 402篇 |
1987年 | 359篇 |
1986年 | 291篇 |
1985年 | 342篇 |
1984年 | 260篇 |
1983年 | 212篇 |
1982年 | 235篇 |
1981年 | 178篇 |
1980年 | 156篇 |
1979年 | 121篇 |
1978年 | 100篇 |
1977年 | 90篇 |
1976年 | 71篇 |
1975年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
121.
122.
本文采用小鼠精子试验和小鼠睾丸DNA合成抑制试验,检测了JX-1对雄性生殖细胞的致突变作用。实验结果表明JX-1对小鼠精子总数、精子活动率及精子畸形率均无统计学意义的增加,与小鼠睾丸DNA合成抑制试验阴性反应一致。作者认为JX-1对雄性生殖细胞为一种非诱变剂。 相似文献
123.
目的分析单侧听耳患者的鼓室成形术,了解手术方法和手术疗效。方法对9耳慢性化脓性中耳炎胆脂瘤型进行了乳突根治术加鼓室成形术,对37耳慢性化脓性中耳炎单纯型和中耳炎后遗症进行鼓室成形术,并比较术后效果。手术后3个月~1年之间进行术后听力评价。结果46耳单侧听力耳术前言语频率气导平均听阈为60.2±23.1dB HL,骨导听阈35.7±17.0dB HL;手术后的平均气导听阈为51.3±22.6dB HL,骨导听阈为36.3±10.6dB HL。鼓室成形术后疗效评定:37耳外耳道宽敞,人工鼓膜完整,血运好,近正常鼓膜色泽;纯音测听500~2000Hz平均气导听力改善23例(62.16%,23/37),听力不变13例(35.14%,13/37),听力恶化(下降10dB以上)1例(2.70%,1/37)。乳突根治术加鼓室成形术后疗效评定:9耳术腔干洁,人工鼓膜完整,血运好,近正常鼓膜色;纯音测听500~2000Hz平均气导听力改善5例(56.56%,5/9),听力不变4例(44.44%,4/9)。结论各型慢性化脓性中耳炎都可作为单侧听力耳的手术适应症。手术时只要注意手术技巧,认真仔细,一般不会造成手术后骨导听力的下降。术后干耳和保持原有听力是手术的最终目的。 相似文献
124.
本文报告乳腺积乳囊肿43例。讨论了发病原因及病理,特别提出局部肿块波动感试验阳性,A超检查显示液平段,试穿抽出乳汁,对诊断有肯定价值;治疗以手术切除为主,仅有7例穿刺抽吸乳汁得以治愈。 相似文献
125.
Margaret Sullivan Pepe Ziding Feng Gary Longton Joseph Koopmeiners 《Statistics in medicine》2009,28(5):762-779
Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate, if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies. We suggest early stopping criteria and estimation procedures that adjust for bias caused by the early termination option. An important aspect of our approach is to focus on properties of estimates conditional on reaching full study enrollment. We propose the conditional‐UMVUE and contrast it with other estimates, including naïve estimators, the well‐studied unconditional‐UMVUE and the mean and median Whitehead‐adjusted estimators. The conditional‐UMVUE appears to be a very good choice. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
126.
127.
中美中学生对由父母原因引起的考试焦虑认知研究 总被引:1,自引:0,他引:1
目的:比较中国和美国的中学生对由父母原因引起的考试焦虑的认知情况。方法:采用“失败结果预期(FOE)”问卷中的由父母原因引起的考试焦虑12项,测量中美两国公立学校14、15岁的1215名中学生对考试焦虑原因的认知。结果:1.相似认知:两国学生在由父母原因引起的考试焦虑方面有类似的认知,包括父母会担心自己能否进入高一级学校、会让父母烦恼等。2.跨文化的差异:表现为中国学生更多是因为父母责备、辜负了父母期望或会让父母生气而导致考试焦虑;而美国学生更多是由于父母认为他们不能面对生活中的挑战而产生焦虑。3.性别差异:表现在美国的女中学生在7个项目上、中国的男中学生在2个项目上分别比本国异性有更大程度的焦虑(P〈0.05)。结论:中美中学生对由父母原因引起的考试焦虑方面有类似的认知,但存在文化差异和性别差异。 相似文献
128.
Padmaja Yalamanchili Eric Wexler Megan Hayes Ming Yu Jody Bozek Mikhail Kagan Heike S. Radeke Michael Azure Ajay Purohit David S. Casebier Simon P. Robinson 《Journal of nuclear cardiology》2007,14(6):782-788
Background
BMS-747158-02 is a novel fluorine 18-labeled pyridazinone derivative designed for cardiac imaging. The uptake and retention
mechanisms of F-18 BMS-747158-02 in cardiac myocytes were studied in vitro, and the biodistribution of F-18 BMS-747158-02
was studied in vivo in mice.
Methods and Results
Fluorine 19 BMS-747158-01 inhibited mitochondrial complex I (MC-I) in bovine heart submitochondrial particles with an IC50 of 16.6±3 nmol/L that was comparable to the reference inhibitors of MC-1, rotenone, pyridaben, and deguelin (IC50 of 18.2±6.7 nmol/L, 19.8±2.6 nmol/L, and 23.1±1.5 nmol/L, respectively). F-18 BMS-747158-02 had high uptake in monolayers
of neonatal rat cardiomyocytes (10.3%±0.7% of incubated drug at 60 minutes) that was inhibited by 200 nmol/L of rotenone (91%±2%)
and deguelin (89%±3%). In contrast, an inactive pyridaben analog, P-0 (IC50 value>4 μmol/L in MC-1 assay), did not inhibit the binding of F-18 BMS-747158-02 in cardiomyocytes. Uptake and washout kinetics
for F-18 BMS-747158-02 in rat cardiomyocytes indicated that the time to half-maximal (t1/2) uptake was very rapid (approximately 35 seconds), and washout t1/2 for efflux of F-18 BMS-747158-02 was greater than 120 minutes. In vivo biodistribution studies in mice showed that F-18 BMS-747158-02
had substatial myocardial uptake (9.5%±0.5% of injected dose per gram) at 60 minutes and heart-to-lung and heart-to-liver
ratios of 14.1±2.5 and 8.3±0.5, respectively. Positron emission tomography imaging in the mouse allowed clear cardiac visualization
and demonstrated sustained myocardial uptake through 55 minutes.
Conclusions
F-18 BMS-747158-02 is a novel positron emission tomography cardiac tracer targeting MC-I in cardiomyocytes with rapid uptake
and slow washout. These characteristics allow fast and sustained accumulation in the heart. 相似文献
129.
130.
Birgit Herting MD Bettina Beuthien‐Baumann MD Katrin Pöttrich PhD Markus Donix MD Antje Triemer PhD Johannes B. Lampe MD Rüdiger von Kummer MD Karl Herholz MD Heinz Reichmann MD Vjera A. Holthoff MD 《Movement disorders》2007,22(4):490-497
Depressive symptoms are common in patients with neurodegenerative disorders. Imaging studies suggest that a disruption of frontal-subcortical pathways may underlie depression associated with basal ganglia disease. This pilot study tested the hypothesis that frontal dysfunction contributes to depression associated with multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Depressed patients with MSA (n = 11), PSP (n = 9), and age-matched controls (n = 25) underwent measures of cerebral glucose metabolism applying positron emission tomography with (18)F-fluorodeoxyglucose. Regional metabolism in the patient groups was compared to the normal subjects using the voxel-based statistical parametric mapping. Depressive symptom severity (Hamilton Depression Rating) and degree of locomotor disability (Hoehn & Yahr) were assessed in the patient groups. The association between prefrontal metabolism and the occurrence of depressive symptoms and the degree of locomotor disability was investigated. When compared to controls, MSA patients revealed significant metabolic decreases in bilateral frontal, parietal, and cerebellar cortex and in the left putamen. In PSP patients, significant hypometabolism was demonstrated in bilateral frontal cortex, right thalamus, and midbrain. Depression severity but not the patients' functional condition was significantly associated with dorsolateral prefrontal glucose metabolism in both patient groups. The findings of this pilot study support the hypothesis that depressive symptoms in MSA and PSP are associated with prefrontal dysfunction. 相似文献